{"id":66442,"date":"2014-07-23T03:47:59","date_gmt":"2014-07-23T07:47:59","guid":{"rendered":"http:\/\/www.eugenesis.com\/should-men-at-risk-for-cardiovascular-disease-receive-earlier-cholesterol-treatment\/"},"modified":"2014-07-23T03:47:59","modified_gmt":"2014-07-23T07:47:59","slug":"should-men-at-risk-for-cardiovascular-disease-receive-earlier-cholesterol-treatment","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/should-men-at-risk-for-cardiovascular-disease-receive-earlier-cholesterol-treatment.php","title":{"rendered":"Should men at risk for cardiovascular disease receive earlier cholesterol treatment?"},"content":{"rendered":"<p><p>    PUBLIC RELEASE DATE:  <\/p>\n<p>    22-Jul-2014  <\/p>\n<p>    Contact: Kathryn Ruehle    <a href=\"mailto:kruehle@liebertpub.com\">kruehle@liebertpub.com<\/a>    914-740-2100    Mary Ann Liebert, Inc.\/Genetic    Engineering News<\/p>\n<p>    New Rochelle, NY -- New guidelines on cholesterol treatment and    cardiovascular risk assessment state that men have at least    double the risk of dying from atherosclerotic cardiovascular    disease or of having a heart attack or stroke as do women with    a similar risk profile (based on age, smoking history, and    cholesterol and blood pressure levels). The implications of    this finding for when and how aggressively to treat high    cholesterol are examined in an Editorial in Journal of Men's    Health, a peer-reviewed publication from Mary Ann Liebert,    Inc., publishers. The article is available free on the    Journal of Men's Health website at <a href=\"http:\/\/online.liebertpub.com\/doi\/full\/10.1089\/jomh.2014.1500\" rel=\"nofollow\">http:\/\/online.liebertpub.com\/doi\/full\/10.1089\/jomh.2014.1500<\/a>    until August 22, 2014.  <\/p>\n<p>    Stephen L. Kopecky, MD, Mayo Clinic, Rochester, MN, and Ajay    Nehra, MD, Rush University Medical Center, Chicago, IL, discuss    the risk factors on which the American College of Cardiology    and the American Heart Association based their new guidelines.    They describe the value in developing 10-year risk and lifetime    risk estimates and their use in educating patients and    encouraging lifestyle changes. The authors note the omission of    erectile dysfunction as a risk marker, and they explain the new    cholesterol treatment recommendations in the Editorial entitled    \"Cardiovascular Risk and Cholesterol Management in Men:    Implications of the New Guidelines.\"  <\/p>\n<p>    ###  <\/p>\n<p>    About the Journal  <\/p>\n<p>    Journal of Men's Health is the premier peer-reviewed    journal published quarterly in print and online that covers all    aspects of men's health across the lifespan. The Journal of    Men's Health publishes cutting-edge advances in a wide    range of diseases and conditions, including diagnostic    procedures, therapeutic management strategies, and innovative    clinical research in gender-based biology to ensure optimal    patient care. The Journal of Men's Health addresses    disparities in health and life expectancy between men and    women; increased risk factors such as smoking, alcohol abuse,    and obesity; higher prevalence of diseases such as heart    disease and cancer; and health care in underserved and minority    populations. Journal of Men's Health meets the critical    imperative for improving the health of men around the globe and    ensuring better patient outcomes. Tables of content and a    sample issue can be viewed on the Journal of Men's    Health website at <a href=\"http:\/\/www.liebertpub.com\/jomh\" rel=\"nofollow\">http:\/\/www.liebertpub.com\/jomh<\/a>.  <\/p>\n<p>    About the Societies  <\/p>\n<p>    Journal of Men's Health is the official journal of the    International Society of Men's Health (ISMH), American Society    for Men's Health, Men's Health Society of India, and Foundation    for Men's Health. The ISMH is an international,    multidisciplinary, worldwide organization, dedicated to the    rapidly growing field of gender-specific men's health.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Here is the original post:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2014-07\/mali-sma072214.php\/RK=0\/RS=3MAsGeXf2TMlWvaiNRFVHzwZjd0-\" title=\"Should men at risk for cardiovascular disease receive earlier cholesterol treatment?\">Should men at risk for cardiovascular disease receive earlier cholesterol treatment?<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> PUBLIC RELEASE DATE: 22-Jul-2014 Contact: Kathryn Ruehle <a href=\"mailto:kruehle@liebertpub.com\">kruehle@liebertpub.com<\/a> 914-740-2100 Mary Ann Liebert, Inc.\/Genetic Engineering News New Rochelle, NY -- New guidelines on cholesterol treatment and cardiovascular risk assessment state that men have at least double the risk of dying from atherosclerotic cardiovascular disease or of having a heart attack or stroke as do women with a similar risk profile (based on age, smoking history, and cholesterol and blood pressure levels).  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/should-men-at-risk-for-cardiovascular-disease-receive-earlier-cholesterol-treatment.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-66442","post","type-post","status-publish","format-standard","hentry","category-genetic-engineering"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/66442"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=66442"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/66442\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=66442"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=66442"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=66442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}